Anzeige
Mehr »
Mittwoch, 18.06.2025 - Börsentäglich über 12.000 News
Entsteht hier die interessanteste spekulative Chance im kommenden Rohstoff-Boom?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
212 Leser
Artikel bewerten:
(1)

Balloon Infusers Market is predicted to surge at a CAGR close to 9% over the forecast period (2021-2031): Persistence Market Research

NEW YORK, July 1, 2021 /PRNewswire/ -- According to a new report published by Persistence Market Research, the global balloon infusers market size valued at US$ 905.7 Mn in 2020, and is predicted to surge at a CAGR close to 9% over the forecast period (2021-2031).

Persistence Market Research Logo

The caregiving model across the world is changing toward evidence-backed systems for better tracking of capital flow, patient progress, and reducing duration of hospital stay. One of the most important requirements of evidence-backed treatment is found in acute pain service (APS).

Balloon infusers, being lightweight and most economical in nature, are witnessing greater adoption in hospitals and home care settings. These are easy to operate and can be controlled by patients and licensed caregivers. These are preferred over electronic pumps as they can deliver fluids at precise volumes, frequencies, and intervals.

Leading pharmaceutical companies are focused on manufacturing user-friendly balloon infusers with regulators and flow sensors for the precise measurement of drug delivery rates. In addition, some players, as part of their strategy to gain a larger market share, are launching balloon infusers with added features.

Request for sample PDF of report: https://www.persistencemarketresearch.com/samples/32517

Key Takeaways from Market Study

  • Continuous rate balloon infusers are expected to contribute around 70% revenue share in the market by 2031.
  • Among all applications, the pain management segment is expected to expand at a CAGR of 10% by 2031. However, chemotherapy is also expected to be the next leading segment, as cancer is one of the leading chronic diseases, and is expected to hold 1/3 market share.
  • Among all the end users, the hospitals segment accounted for more than 40% market share in 2020.
  • North America holds the highest share in the global balloon infusers market, while East Asia is the next leading region, due to various technological advancements in the balloon infusers.
  • The U.S. holds a big portion of global revenue and accounts for around 90% share in the North American market.

Know the methodology of report by asking an expert: https://www.persistencemarketresearch.com/ask-an-expert/32517

"Increasing number of chronic diseases, rising adoption of balloon infusers, ongoing COVID-19 pandemic, and technologically advanced products are factors expected to drive market growth over the coming years," says an analyst of Persistence Market Research.

Innovative Product Bundling Strategies Creating Sustainable Demand

Balloon infuser manufacturers are progressively concentrating on bundling related accessories and IV drug to increase their market penetration. In this regard, dependence on direct sales visits is rising in economies such as India and China.

Visits directly by sales personnel lead to chances for the training of staff to be tasked with delivering drugs to patients. This builds goodwill on the part of producers and the possibility of contract deals from end user. Attractive, effective margin bargaining and pricing are strategies anticipated to boost future sales of balloon infusers.

Get full access of report: https://www.persistencemarketresearch.com/checkout/32517

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the balloon infusers market in its latest study, presenting a historical demand assessment of 2016 - 2020 and projections for 2021 - 2031.

The research study is based on the product (continuous rate balloon infusers and variable rate balloon infusers), application (pain management, antibiotic therapy, antiviral therapy, chemotherapy, and others), and end user (hospitals, ambulatory surgical centers, home care settings, speciality clinics, and others), across seven key regions of the world.

Related Reports:

  • PTCA Balloon Catheter Market
  • Balloon Assisted Coiling Market
  • Intra-Aortic Balloon Pump Market
  • Peripheral Drug Eluting Balloon Market
  • Drug Eluting Balloons Market
  • Neurovascular Remodelling Balloons Market
  • Holographic Films Market

About Persistence Market Research:

Persistence Market Research (PMR), as a 3rd-party research organization, does operate through an exclusive amalgamation of market research and data analytics for helping businesses ride high, irrespective of the turbulence faced on the account of financial/natural crunches.

Overview:

Persistence Market Research is always way ahead of its time. In other words, it tables market solutions by stepping into the companies'/clients' shoes much before they themselves have a sneak pick into the market. The pro-active approach followed by experts at Persistence Market Research helps companies/clients lay their hands on techno-commercial insights beforehand, so that the subsequent course of action could be simplified on their part.

Contact

Rajendra Singh
Persistence Market Research
U.S. Sales Office:
305 Broadway, 7th Floor
New York City, NY 10007
+1-646-568-7751
United States
USA - Canada Toll-Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Visit Our Website: https://www.persistencemarketresearch.com

Logo: https://mma.prnewswire.com/media/661339/Persistence_Market_Research.jpg

© 2021 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.